Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:4:p17
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 4 (pt 17/22)
Character Range: 233022–236492

rhizome and/or root in the teabag does not exceed 3 g;
  and, where containing more than 25 mg of kavalactones per dose, compliant with the requirements of the required advisory statements for medicine labels; or
 (b) in topical preparations for use on the rectum, vagina or throat containing dried whole or peeled rhizome and/or root or containing aqueous dispersions or aqueous extracts of whole or peeled rhizome and/or root; or
 (c) in dermal preparations.
PIPERACILLIN.
PIPERIDINE.
PIPERIDOLATE.
PIPOBROMAN.
PIPOTHIAZINE.
PIPRADROL.
PIRACETAM.
PIRBUTEROL.
PIRENOXINE (catalin).
PIRENZEPINE.
PIRETANIDE.
PIRFENIDONE.
PIROXICAM except in preparations for dermal use.
PIRPROFEN.
PITAVASTATIN.
PITUITARY HORMONES except when separately specified in these Schedules.
PIVAMPICILLIN.
PIZOTIFEN.
PLICAMYCIN.
PLITIDEPSIN.
PLERIXAFOR.
PNEUMOCOCCAL VACCINE.
PODOPHYLLOTOXIN for human use:
 (a) internally; or
 (b) in preparations for the treatment of anogenital warts; or
 (c) in other preparations except when included in Schedule 2 or 3.
PODOPHYLLUM EMODI (podophyllin) for human use:
 (a) internally; or
 (b) in preparations for the treatment of anogenital warts; or
 (c) in other preparations except when included in Schedule 2 or 3.
PODOPHYLLUM PELTATUM (podophyllin) for human use:
 (a) internally; or
 (b) in preparations for the treatment of anogenital warts; or
 (c) in other preparations except when included in Schedule 2 or 3.
POLIDEXIDE.
POLIOMYELITIS VACCINE.
POLYACRYLAMIDE in preparations for injection or implantation:
 (a) for tissue augmentation; or
 (b) for cosmetic use; or
 (c) for veterinary use.
POLYCAPROLACTONE in preparations for injection or implantation:
 (a) for tissue augmentation; or
 (b) for cosmetic use.
POLYESTRADIOL.
POLYLACTIC ACID in preparations for injection or implantation:
 (a) for tissue augmentation; or
 (b) for cosmetic use.
POLYMYXIN.
POLYSULFATED GLYCOSAMINOGLYCANS in preparations for injection, except when separately specified in these Schedules.
POLYTHIAZIDE.
POMALIDOMIDE.
PONATINIB.
PONESIMOD.
PORACTANT.
POSACONAZOLE.
POTASSIUM BROMIDE for therapeutic use.
POTASSIUM CHLORIDE in oral preparations for human therapeutic use except:
 (a) when containing less than 550 mg of potassium chloride per dosage unit; or
 (b) in preparations for oral rehydration therapy; or
 (c) in preparations for oral use for bowel cleansing prior to diagnostic medical and surgical procedures; or
 (d) in preparations for enteral feeding.
POTASSIUM PERCHLORATE for therapeutic use.
PRACTOLOL.
PRADOFLOXACIN.
PRALATREXATE.
PRALIDOXIME.
PRAMIPEXOLE.
PRAMIRACETAM.
PRAMOCAINE.
# PRALMORELIN (GROWTH HORMONE RELEASING PEPTIDE‑2 (GHRP‑2)).
PRALSETINIB.
PRAMPINE.
# PRASTERONE (dehydroepiandrosterone, dehydroisoandrosterone).
PRASUGREL.
PRAVASTATIN.
# PRAZEPAM.
PRAZIQUANTEL for human therapeutic use.
PRAZOSIN.
PREDNISOLONE.
PREDNISONE.
PREGABALIN.
PREGNENOLONE.
PRENALTEROL.
PRENYLAMINE.
PRILOCAINE except when included in Schedule 2.
PRIMAQUINE.
PRIMIDONE.
PROBENECID.
PROBUCOL.
PROCAINAMIDE.
PROCAINE.
PROCAINE BENZYLPENICILLIN.
PROCARBAZINE.
PROCHLORPERAZINE except when included in Schedule 3.
PROCYCLIDINE except when included in Schedule 2.
PROGESTERONE except when included in Schedule 5.
PROGESTOGENS except when separately specified in these Schedules.
PROGLUMIDE.
PROGUANIL.
PROLINTANE.
PROMAZINE.
PROMETHAZINE except when included in Schedule 2 or 3.
PROMOXOLANE.
PROPAFENONE.
PROPAMIDINE for therapeutic use except when included in